193
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Risk Factors, Characteristics, and Outcome in Non-Ventilated Patients with Spontaneous Pneumothorax or Pneumomediastinum Associated with SARS-CoV-2 Infection

ORCID Icon, ORCID Icon, ORCID Icon, , , & show all
Pages 489-500 | Published online: 11 Jan 2022

References

  • Noppen M. Spontaneous pneumothorax: epidemiology, pathophysiology and cause. Eur Respir Rev. 2010;19(117):217–219. doi:10.1183/09059180.00005310
  • Zhu H, Wei L, Niu P. The novel coronavirus outbreak in Wuhan, China. Glob Heal Res Policy. 2020;5(1). doi:10.1186/s41256-020-00135-6
  • Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(3):141–154. doi:10.1038/s41579-020-00459-7
  • Palumbo D, Campochiaro C, Belletti A, et al. Pneumothorax/Pneumomediastinum in non-intubated COVID-19 patients: differences between first and second Italian pandemic wave. Eur J Intern Med. 2021;88:144–146. doi:10.1016/j.ejim.2021.03.018
  • Guven BB, Erturk T, Kompe Ö, Ersoy A. Serious complications in COVID-19 ARDS cases: pneumothorax, pneumomediastinum, subcutaneous emphysema and haemothorax. Epidemiol Infect. 2021;149:e137. doi:10.1017/S0950268821001291
  • Miró Ò, Llorens P, Jiménez S, et al. Frequency, risk factors, clinical characteristics, and outcomes of spontaneous pneumothorax in patients with coronavirus disease 2019: a case-control, emergency medicine-based multicenter study. Chest. 2021;159(3):1241–1255. doi:10.1016/j.chest.2020.11.013
  • Martinelli AW, Ingle T, Newman J, et al. COVID-19 and pneumothorax: a multicentre retrospective case series. Eur Respir J. 2020;56(5):2002697. doi:10.1183/13993003.02697-2020
  • Chong WH, Saha BK, Hu K, Chopra A. The incidence, clinical characteristics, and outcomes of pneumothorax in hospitalized COVID-19 patients: a systematic review. Hear Lung. 2021;50(5):599–608. doi:10.1016/j.hrtlng.2021.04.005
  • Ekanem E, Podder S, Donthi N, et al. Spontaneous pneumothorax: an emerging complication of COVID-19 pneumonia. Hear Lung. 2021;50(3):437–440. doi:10.1016/j.hrtlng.2021.01.020
  • Greenberg DJ, Nabors C, Chandy D, Dhand A. Pneumothorax and pneumomediastinum in patients hospitalized with coronavirus disease 2019 (COVID-19). Heart Lung. 2021;50(3):386–387. doi:10.1016/j.hrtlng.2021.02.006
  • Cabrera Gaytán DA, Pérez Andrade Y, Espíritu Valenzo Y. Pneumothorax due to COVID-19: analysis of case reports. Respir Med Case Rep. 2021;34:101490. doi:10.1016/j.rmcr.2021.101490
  • López Vega JM, Parra Gordo ML, Diez Tascón A, Ossaba Vélez S. Pneumomediastinum and spontaneous pneumothorax as an extrapulmonary complication of COVID-19 disease. Emerg Radiol. 2020;27(6):727–730. doi:10.1007/s10140-020-01806-0
  • Marza AM, Petrica A, Buleu FN, Mederle OA. Case report: massive spontaneous pneumothorax—a rare form of presentation for severe COVID-19 pneumonia. Medicina. 2021;57(2):82. doi:10.3390/medicina57020082
  • Shan S, Guangming L, Wei L, Xuedong Y. Spontaneous pneumomediastinum, pneumothorax and subcutaneous emphysema in COVID-19: case report and literature review. Rev Inst Med Trop Sao Paulo. 2020;62:e76. doi:10.1590/S1678-9946202062076
  • Gray WK, Navaratnam AV, Day J, et al. Variability in COVID-19 in-hospital mortality rates between national health service trusts and regions in England: a national observational study for the getting it right first time programme. EClinicalMedicine. 2021;35:100859. doi:10.1016/j.eclinm.2021.100859
  • Aragón MJ, Chalkley M. How do time trends in inhospital mortality compare? A retrospective study of England and Scotland over 17 years using administrative data. BMJ Open. 2018;8(2):e017195. doi:10.1136/bmjopen-2017-017195
  • Miró Ò, Jiménez S, Mebazaa A, et al. Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome. Eur Heart J. 2021;42(33):3127–3142. doi:10.1093/eurheartj/ehab314
  • van Smeden M, Moons KGM, de Groot JAH, et al. Sample size for binary logistic prediction models: beyond events per variable criteria. Stat Methods Med Res. 2019;28(8):2455–2474. doi:10.1177/0962280218784726
  • Thabane L, Mbuagbaw L, Zhang S, et al. A tutorial on sensitivity analyses in clinical trials: the what, why, when and how. BMC Med Res Methodol. 2013;13(1):92. doi:10.1186/1471-2288-13-92
  • Demidenko E. Sample size determination for logistic regression revisited. Stat Med. 2007;26(18):3385–3397. doi:10.1002/sim.2771
  • Zhang Z, Yuan KH. Practical Statistical Power Analysis Using WebPower and R. Notre Dame. Indiana, USA: ISDSA Press; 2018.
  • Hsieh FY, Bloch DA, Larsen MD. A simple method of sample size calculation for linear and logistic regression. Stat Med. 1998;17(14):1623–1634. doi:10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S
  • Altman DG. Practical Statistics for Medical Research. London: Chapman and Hall; 1991.
  • Dionísio P, Martins L, Moreira S, et al. Spontaneous pneumomediastinum: experience in 18 patients during the last 12 years. J Bras Pneumol. 2017;43(2):101–105. doi:10.1590/s1806-37562016000000052
  • Buford TW. Hypertension and aging. Ageing Res Rev. 2016;26:96–111. doi:10.1016/j.arr.2016.01.007
  • Qu G, Chen J, Huang G, et al. A quantitative exploration of symptoms in COVID-19 patients: an observational cohort study. Int J Med Sci. 2021;18(4):1082–1095. doi:10.7150/ijms.53596
  • Tabernero E, Ruiz LA, España PP, et al. COVID-19 in young and middle-aged adults: predictors of poor outcome and clinical differences. Infection. 2020. PMID: 34463951. doi:10.1007/s15010-021-01684-9
  • Liu FY, Sun XL, Zhang Y, et al. Evaluation of the risk prediction tools for patients with coronavirus disease 2019 in Wuhan, China: a single-centered, retrospective, observational study. Crit Care Med. 2020;48(11):e1004–e1011. doi:10.1097/CCM.0000000000004549
  • Palumbo D, Zangrillo A, Belletti A, et al.; COVID-BioB Study Group. A radiological predictor for pneumomediastinum/pneumothorax in COVID-19 ARDS patients. J Crit Care. 2021;66:14–19. doi:10.1016/j.jcrc.2021.07.022.
  • Blanc K, Bonnet N, Ouedraogo E, Arnaout M, Patout M, Tandjaoui-Lambiotte Y. Interstitial lung disease-related pneumomediastinum in COVID-19 patients. ERJ Open Res. 2021;7(1):00014–2021. doi:10.1183/23120541.00014-2021
  • Ulutas H, Celik MR, Gulcek I, et al. Management of spontaneous pneumothorax in patients with COVID-19. Interact Cardiovasc Thorac Surg. 2021. doi:10.1093/icvts/ivab280
  • Owens C, Amin H, Alwan S, Mitra I. Delayed spontaneous pneumothorax presentation in Covid-19: case series and review. Front Int J Gen Med. 2021;14:2989–3000. doi:10.47746/FMCR.2020.1603
  • Kawachi J, Koyama H, Aida Y. Pneumothorax with coronavirus disease 2019 in non-ventilated patients: a single-center retrospective case series. Authorea Preprints. 2021. PPR: PPR368231. doi:10.22541/au.162602191.11443821/v1.
  • Chopra A, Al-Tarbsheh AH, Shah NJ, et al. Pneumothorax in critically ill patients with COVID-19 infection: incidence, clinical characteristics and outcomes in a case control multicenter study. Respir Med. 2021;184:106464. doi:10.1016/j.rmed.2021.106464
  • Bor C, Demirağ K, Uyar M, Cankayalı I, Moral AR. Recurrent spontaneous pneumothorax during the recovery phase of ARDS due to H1N1 infection. Balkan Med J. 2013;30(1):123–125. doi:10.5152/balkanmedj.2012.086
  • Al-Shokri SD, Ahmed AOE, Saleh AO, AbouKamar M, Ahmed K, Mohamed MFH. Case Report: COVID-19–related pneumothorax—case series highlighting a significant complication. Am J Trop Med Hyg. 2020;103(3):1166–1169. doi:10.4269/ajtmh.20-0713
  • Cut TG, Tudoran C, Lazureanu VE, Marinescu AR, Dumache R, Tudoran M. Spontaneous pneumomediastinum, pneumothorax, pneumopericardium and subcutaneous emphysema—Not so uncommon complications in Patients with COVID-19 pulmonary infection—A series of cases. J Clin Med. 2021;10(7):1346. doi:10.3390/jcm10071346
  • Shaikh N, Al Ameri G, Shaheen M, et al. Spontaneous pneumomediastinum and pneumothorax in COVID-19 patients: a tertiary care experience. Health Sci Rep. 2021;4(3):e339. doi:10.1002/hsr2.339
  • Shaikh N, Al Ameri G, Shaheen M, et al. Tension Pneumomediastinum: a life-threatening condition in patients with COVID-19. Qatar Med J. 2021;2021(3):55. doi:10.5339/qmj.2021.55